Skip to main content
. 2022 Dec 12;42(2):e110553. doi: 10.15252/embj.2021110553

Figure 1. TGF‐β decreases the abundance of glycosphingolipid (GSL)‐glycans.

Figure 1

  • A, B
    Average copy numbers of (A) total GSL‐glycans and (B) individual GSL‐glycans per cell in NMuMG cells stimulated with TGF‐β.
  • C, D
    Average copy numbers of (C) total GSL‐glycans and (D) individual GSL‐glycans per cell in A549‐VIM‐RFP cells treated with TGF‐β.
  • E
    GSL biosynthesis scheme. GSLs present in both NMuMG cells, and A549‐VIM‐RFP cells are highlighted by red boxes.
  • F, G
    Immunoblot analysis of ST3GAL5 in (F) NMuMG and (G) A549‐VIM‐RFP cells treated with vehicle control or TGF‐β for the indicated time. Vinculin and GAPDH: loading controls.

Data information: Unless stated otherwise, TGF‐β (2.5 ng/ml) and vehicle control were applied for 48 h. The histograms show the mean ± SD values from three biological replicates (n = 3). *P ≤ 0.05; **P < 0.01 based on unpaired Student's t‐test. GT1b: internal normalization control.